NCIC Clinical Trials Group: Lymphoma trials
The registry lists 13 Lymphoma studies with NCIC Clinical Trials Group as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 1 2Phase 2 6Phase 3 4No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaCompletedNCT00078949Phase 3Results posted
- A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed Mantle Cell LymphomaCompletedNCT01652144Phase 2
- Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00443976Phase 1
- Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's LymphomaCompletedNCT00428142Phase 2
- AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's LymphomaCompletedNCT00390117Phase 1
- Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell LymphomaCompletedNCT00377052Phase 2
- Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's LymphomaCompletedNCT00064116Phase 3
- Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell TransplantationCompletedNCT00031668Not applicable
- Bortezomib in Treating Patients With Mantle Cell LymphomaCompletedNCT00030875Phase 2
- Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous TreatmentCompletedNCT00014209Phase 2
- Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell LymphomaCompletedNCT00005074Phase 2
- Treatment for Chronic Pain in Patients With Advanced CancerCompletedNCT00003687Phase 3
- Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's DiseaseCompletedNCT00002561Phase 3